Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 138
Aptamer sequence: GGGAGACAAGAAUAAACGCUCAAGUGACGUCCUGAUCGAUUGUGCAUUCGGUGUGACGAUCUUUCGACAGGAGGCUCACAACAGGC
Target unique ID: P01730
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_137 aptamer 12 Protein CD4_HUMAN 0.5 nM 1 ml PBS containing 2 mM MgCl2 9705498
Structure information of aptamer
Aptamer Sequence: GGGAGACAAGAAUAAACGCUCAAGUGACGUCCUGAUCGAUUGUGCAUUCGGUGUGACGAUCUUUCGACAGGAGGCUCACAACAGGC
The optimal secondary structure in dot-bracket notation: .................(((...((((..(((((.((((((((((((...)))).))))....)))))))))...))))....)))
The centroid secondary structure in dot-bracket notation: .................((....((((..(((((.(((((((((((.....))).))))....)))))))))...)))).....))
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_137 Description aptamer 12
Aptamer chemistry RNA Length 86 nt
GC content 51.2% Molecular weight 28,018.49 Da
Molarity of 1 μg/μl solution 35.69 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted binding
Sequence GGGAGACAAGAAUAAACGCUCAAGUGACGUCCUGAUCGAUUGUGCAUUCGGUGUGACGAUCUUUCGACAGGAGGCUCACAACAGGC
Applications Stained CD4+ T cells in a preparation of human peripheral blood mononuclear cells
Target information
Type Detail Type Detail
Uniprot ID P01730 Protein name T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4)
Gene name(s) CD4 Organism T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4)
Status reviewed in uniprot database Length 458
Mass 51,111 Activity regulation N/A
Involvement in disease Immunodeficiency 79 (IMD79) Catalytic activity N/A
PDB ID(s)
1CDH;1CDI;1CDJ;1CDU;1CDY;1G9M;1G9N;1GC1;1JL4;1Q68;1RZJ;1RZK;1WBR;1WIO;1WIP;1WIQ;2B4C;2JKR;2JKT;2KLU;2NXY;2NXZ;2NY0;2NY1;2NY2;2NY3;2NY4;2NY5;2NY6;2QAD;3B71;3CD4;3J70;3JCB;3JCC;3JWD;3JWO;3LQA;3O2D;3S4S;3S5L;3T0E;4H8W;4JM2;4P9H;4Q6I;4R2G;4R4H;4RQS;5A7X;5A8H;5CAY;5THR;5U1F;5VN3;6CM3;6EDU;6L1Y;6MEO;6MET;6OPN;6OPO;6OPP;6OPQ;6QH6;6QH7;6U0L;6U0N;6URI;6X5B;6X5C;7T0O;7T0R;
Function Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses.
Activity data
Interaction ID 138
Target type Protein
Target unique ID P01730
Activity 0.5 nM
Binding Conditions/Buffer

1 ml PBS containing 2 mM MgCl2

Assay

Binding analysis of a representative aptamer from each of the four classes. Biotinylated RNA aptamer sequences complexed to SA-PE were incubated with CD4 presented on L200 beads and then analyzed by flow cytometry. The mean fluoresence of beads was plotted against the concentration of Aptamer:SA-PE complex

PubMed ID 9705498
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_432 RNA GGGAGACAAGAAUAAACGCUCAAGGCAUUUCUGCUAGUCUGGUUGUAAGAUAUUCAACACGUGAGUUUCGACAGGAGGCUCACAACAGGC 74.44%
Apta_433 RNA GGGAGACAAGAAUAAACGCUCAACGUUCAGUAUAACAGUCCGAGUCUAACACACAAUGGGACACUGAAUUCGACAGGAGGCUCACAACAGGC 72.83%
Apta_272 RNA GGGAGACAAGAAUAAACGCUCAACACAGAACGCGGUCCCCACACAGGACAGGAGCCAGCCCCGGUUCGACAGGAGGCUCACAACAGGC 68.18%
Apta_854 RNA GGGAGCUCAGAAUAAACGCUCAAGGGUAGGGAUCGUUACCCCGACAUUUUAAUGGGCCGAUGUUUCGACAUGAGGCCCGGAUCCGGC 66.67%
Apta_171 RNA GGGAGCUCAGAAUAAACGCUCAACCAGUCUUGUGGCUUUGAAAGAGAGGAGUGUUCGACAUGAGGCCCGGAUCCGGC 66.28%
Apta_790 DNA GGGAGACAAGAATAAACGCTCAAGAAGTGAAAATGACAGAACACAACATTCGACAGGAGGCTCACAACAGGC 65.12%
Apta_490 DNA GGGAGACAAGAATAAACGCTCAAGGGCGTGGTGGGTGGGGTACTAATAATGTGCGTTTGTTCGACAGGAGGCTCACAACAGGC 62.79%
Apta_502 DNA GGGAGACAAGAATAAACGCTCAAATGGACTTTTGAATGTGGCAACAAATTCGACAGGAGGCTCACAACAGGC 62.79%
Apta_501 DNA GGGAGACAAGAATAAACGCTCAATTTAACGTATTTATTCAAGCTCGTATTCGACAGGAGGCTCACAACAGGC 59.30%
Apta_723 RNA GGGAGCUCAGAAUAAACGCUCAAAUCCGUGGACAGGGCGUAAGCGCCUUCGACAUGAGACACGGAUCCUGCGACGAAUUCAGC 59.30%
Apta_170 RNA GGGAGACAAGACUAGACGCUCAAUGUGGGCCACGCCCGAUUUUACGCUUUUACCCGCACGCGAUUGGUUUGUUUCCC 56.98%
Apta_414 RNA GGGAGGACGAUGCGGCCGAUUAGAACUGGGCUGAGGCGUUCUGCAUUUCGGUGAUCAGACGACUCGCUGAGGAUCCGAGA 56.98%
Apta_415 RNA GGGAGGACGAUGCGGAAACUCAUCGGUAGCCUUCCUGCGGUCAGUCUAUUAGGACCAGACGACUCGCUGAGGAUCCGAGA 55.81%
Apta_169 RNA GGGAGACAAGACUAGACGCUCAAUGUGGGCCACGCCCGAUUUUACGCUUUUACCCGCACGCGAUUGGUUUGUUUUCGACAUGAGACUCACAACAGUUCCCUUUAGUGAGGGUUAAUU 55.56%
Apta_719 RNA GGAAUGGAUCCACAUCUACGAAGGCUUUGAAGGUGAGACCGUGCAAAUGAGGAUGGUGUGGAUGAUUAGGGUUGUCGGUUUUCACUGCAGACUUGACGAAGCUU 54.81%
Apta_1222 RNA GGAGGCGCCAACUGAAUGAAACCGUGCUAAGGAGUUGGACUCCGCUGCUUCGGCAGAGCGAUAUAGUGCCAGCUGAUACAUCCGUAACUAGUCGCGUCAC 54.00%
Apta_816 RNA GGGUUCACUGCAGACUUGACGAAGCUUGAGAGAUGCCCCCUGAUGUGCAUUCUUGUUGUGUUGCGGCAAUGGAUCCACAUCUACGAAUUC 53.33%
Apta_1225 RNA GGAGGCGCCAACUGAAUGAAAGAGGUAACGAAAGAUGAUUGUGCCUGCUUCGGCAGUACAACUUCUCGGAUAAAUGAUUAUCCGUAACUAGUCGCGUCAC 53.00%
Apta_256 RNA GGGCGCUAAGUCCUCGCUCAUGCGCGUCCCAUGGGGUAUAGAGGGGUCGAAGUGGACGCGCGACUCGGAUCCU 52.33%
Apta_624 RNA GGGAAUGGAUCCACAUCUACGAAUUCGAAUUGCCGUAAUUUCCCGUGGAGCGAUGCUUCACUGCAGACUUGACGAAGCUU 52.33%